Possible Consequences of a Shortage of Hydroxychloroquine for Lupus Patients Amid the COVID-19 Pandemic.
J Rheumatol. 2020 Apr 08;:
Authors: Peschken CA
As the COVID-19 pandemic took hold in North America, rheumatology clinics across the continent were inundated with phone calls from lupus patients understandably fearful of COVID-19. One of the most common questions from patients was whether they should stop taking their lupus medications.
PMID: 32269064 [PubMed - as supplied by publisher]